Abstract

Culture-independent molecular techniques have advanced the characterization of environmental and human samples including the human milk (HM) bacteriome. However, extraction of high-quality genomic DNA that is representative of the bacterial population in samples is crucial. Lipids removal from HM prior to DNA extraction is common practice, but this may influence the bacterial population detected. The objective of this study was to compare four commercial DNA extraction kits and lipid removal in relation to HM bacterial profiles. Four commercial DNA extraction kits, QIAamp® DNA Microbiome Kit, ZR Fungal/Bacterial DNA MiniPrep™, QIAsymphony DSP DNA Kit and ZymoBIOMICS™ DNA Miniprep Kit, were assessed using milk collected from ten healthy lactating women. The kits were evaluated based on their ability to extract high quantities of pure DNA from HM and how well they extracted DNA from bacterial communities present in a commercial mock microbial community standard spiked into HM. Finally, the kits were evaluated by assessing their extraction repeatability. Bacterial profiles were assessed using Illumina MiSeq sequencing targeting the V4 region of the 16S rRNA gene. The ZR Fungal/Bacterial DNA MiniPrep™ and ZymoBIOMICS™ DNA Miniprep (Zymo Research Corp., Irvine, CA, USA) kits extracted the highest DNA yields with the best purity. DNA extracted using ZR Fungal/Bacterial DNA MiniPrep™ best represented the bacteria in the mock community spiked into HM. In un-spiked HM samples, DNA extracted using the QIAsymphony DSP DNA kit showed statistically significant differences in taxa prevalence from DNA extracted using ZR Fungal/Bacterial DNA MiniPrep™ and ZymoBIOMICS™ DNA Miniprep kits. The only difference between skim and whole milk is observed in bacterial profiles with differing relative abundances of Enhydrobacter and Acinetobacter. DNA extraction, but not lipids removal, substantially influences bacterial profiles detected in HM samples, emphasizing the need for careful selection of a DNA extraction kit to improve DNA recovery from a range of bacterial taxa.

Highlights

  • There is a growing interest in the role that human milk (HM) microbes play in infant and maternal health

  • Randomized clinical trials have shown that the clinical signs of mastitis were alleviated among women with staphylococcal lactational mastitis after the oral administration of HM-derived Lactobacillus salivarius and Lactobacillus gasseri strains as compared with the control group who ingested the placebo; HM bacteria may serve as an alternative treatment for lactational infectious mastitis caused by Staphylococcus aureus [3,4]

  • When comparing bacterial 16S DNA concentration from HM samples, using quantitative polymerase chain reaction (qPCR), no significant difference was observed between kits (p = 0.253) (Figure S2A)

Read more

Summary

Introduction

There is a growing interest in the role that human milk (HM) microbes play in infant and maternal health. The HM microbiota has been shown to have a role in the development of the infant gut bacteriome and in promoting programming of the immune system [1,2]. Studies characterizing the bacterial diversity in HM initially were based on culture-dependent techniques, which had several limitations including detection of only viable organisms and being labor-intensive [5,6,7]. Culture-independent molecular techniques, enabled by next-generation sequencing (NGS), can profile bacteria in complex environments and provide detailed phylogenetic information [8,9]. High-quality genomic DNA that is representative of the microbial communities is required

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call